Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05325112 · ClinicalTrials.gov registry record
Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department
A clinical trial, sponsored by HeartFlow.
- Terminated
- Registry status
- 18
- Enrollment target
NCT05325112: Clinical Trial study, sponsored by HeartFlow.
NCT05325112 is a clinical trial that was terminated before completion, run by HeartFlow. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05325112 was terminated before completion, sponsored by HeartFlow.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This is a prospective multi-center study. All clinically stable, symptomatic patients who present to the emergency department (ED) or observation unit with suspected coronary artery disease (CAD) and who have at least one ≥40% lesion and no lesion \>90% confirmed by CCTA (Coronary Computed Tomography Angiogram) are eligible for enrollment once their CCTA has been completed and their FFR-CT (if applicable) has been ordered. All enrolling sites will have CCTA incorporated into their standard evaluation of chest pain in the ED/observation unit. Non-control sites will have CCTA and FFR-CT analysis incorporated into their standard evaluation of chest pain in the ED/observation unit.
Primary Outcome
For each enrolled patient, investigators used data from coronary CTA,along with the clinical data such as medical history and demographics todetermine the management plan for the patient. The investigator wouldthen also view the patient's FFR-CT results and determine themanagement plan for the patient with the additional information from theFFR-CT. None of the data was collected or analyzed due to the study'searly termination. No additional procedures occurred due to studytermination, and Patien
Interventions
- DIAGNOSTIC_TEST FFR-CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2022-11-14 |
Why NCT05325112 stopped before completion
NCT05325112 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FFR-CT is the first listed.
NCT05325112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05325112 about?
NCT05325112 is a clinical study titled "Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department". This is a prospective multi-center study. All clinically stable, symptomatic patients who present to the emergency department (ED) or observation unit with suspected coronary artery disease (CAD) and who have at least one ≥40% lesion and no lesion \>90% confirmed by CCTA (Coronary Computed Tomograph...
What is the current status of trial NCT05325112?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2022-07-15. Estimated completion is 2022-11-14.
What interventions are being tested in trial NCT05325112?
The interventions under investigation include: FFR-CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05325112?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI